Arcturus Therapeutics Holdings Inc (ARCT)
$11.03 -9.22% Close Oct 30, 2026 Live
Arcturus Therapeutics stock today
Arcturus Therapeutics closed at $11.03 on October 30, 2026, down 9.22% on the day. Over the past year it returned +14.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $314 million.
$5.00$10.00$15.00
NovJan 2026MarMayJulSep
| Period | ARCT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -19.4% | -0.9% |
| 3 months | +86.3% | +2.1% |
| Year to date | +79.9% | +11.7% |
| 1 year | +14.5% | +12.4% |
| 3 years | -40.9% | +88.5% |
| 5 years | -75.5% | +76.0% |
Key statistics
- Market value
- $314M
- Price / sales
- 10.7
- 52-week range
- $5.53 to $16.93
- Next report
- Nov 5, 2026
About Arcturus Therapeutics
Biopharmaceutical company developing RNA-based therapies for infectious and genetic diseases.
Sector: Health Care
More on Arcturus Therapeutics
- Financials: revenue, earnings and segmentsRevenue -46% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $820.69 today
No forecast, no recommendation. This page describes Arcturus Therapeutics Holdings Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.